BRD-K85853281 (BRD-K85853281)
Overview
- pert_id
- BRD-K85853281
- Name
- BRD-K85853281
- Collection
- STRD
- MOA
- Unknown
- Target(s)
- Unknown
- Indication(s)
- Unknown
- Phase
- Unknown
- Canonical SMILES
- C[C@@H]1O[C@H](C[C@H](N)[C@@H]1O)O[C@@H]1C[C@](O)(Cc2c(O)c3C(=O)c4ccccc4C(=O)c3c(O)c12)C(C)=O
- InChI key
- InChIKey=XDXDZDZNSLXDNA-LGVQOGFTSA-N
- InChI string
- InChI=1S/C26H27NO9/c1-10-21(29)15(27)7-17(35-10)36-16-9-26(34,11(2)28)8-14-18(16)25(33)20-19(24(14)32)22(30)12-5-3-4-6-13(12)23(20)31/h3-6,10,15-17,21,29,32-34H,7-9,27H2,1-2H3/t10-,15-,16+,17-,21+,26+/m0/s1
- Molecular formula
- C26H27NO9
- Molecular weight
- 497.494
External links
- PubChem
- 151582
- SEP-L1000
- BRD-K85853281
Predicted MOAs
| MOA | Probability |
|---|---|
| topoisomerase inhibitor | 0.9928 |
| HSP inhibitor | 0.0008 |
| tubulin polymerization inhibitor | 0.0007 |
| protein synthesis inhibitor | 0.0006 |
| retinoid receptor agonist | 0.0005 |
| MEK inhibitor | 0.0004 |
| CDK inhibitor | 0.0003 |
| EGFR inhibitor | 0.0003 |
| estrogen receptor agonist | 0.0003 |
| NFkB pathway inhibitor | 0.0003 |
Chemical structure
